person · Reporting owner

Tallett Elizabeth E

Disclosed activity across 5 companies

Tapewire entity: 48709
SEC CIK: 0001192460

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Elevance Health, Inc.ELV · Entity 2934	Director	May 15, 2024	May 17, 2024
Moderna, Inc.MRNA · Entity 2025	Director	May 06, 2026	May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Elevance Health, Inc.

Report date May 15, 2024 · Filed May 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	10,291	Reported balance After 2024-05-15 transaction · row 1 1 source row Row 1 · 2024-05-15 · Grant · Acquired 388 · Balance 10,291 F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Moderna, Inc.

Report date May 06, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	8,371	Reported balance After 2026-05-06 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-06 · Grant · Acquired 8,371 · Balance 8,371 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Hawkeye Acquisition, Inc.

Report date December 01, 2021 · Filed December 03, 2021

Section 16 reporting ended · disclosed 2021-12-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-01 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2021-12-01 · Disposition to issuer · Disposed 28,915 · Balance 0 F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis.
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	31,290	Reported balance After 2021-12-01 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2021-12-01 · Exercise / conversion · Acquired 4,697 · Balance 31,290
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	0	Reported balance After 2021-12-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-12-01 · Disposition to issuer · Disposed 8,100 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	0	Reported balance After 2021-12-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-12-01 · Disposition to issuer · Disposed 4,064 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	0	Reported balance After 2021-12-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-12-01 · Disposition to issuer · Disposed 3,912 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-12-01 · Disposition to issuer · Disposed 4,389 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	0	Reported balance After 2021-12-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-01 · Disposition to issuer · Disposed 5,685 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	0	Reported balance After 2021-12-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-12-01 · Disposition to issuer · Disposed 5,936 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	0	Reported balance After 2021-12-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-12-01 · Disposition to issuer · Disposed 4,697 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis. F4: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	0	Reported balance After 2021-12-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-12-01 · Disposition to issuer · Disposed 8,161 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-12-01 · Disposition to issuer · Disposed 11,692 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Stock equivalent unitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-12-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-12-01 · Disposition to issuer · Disposed 25,282 · Balance 0 F5: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards. F6: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis.

F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option.

F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.

F4: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date.

F5: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards.

F6: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Meredith Holdings Corp

Report date December 01, 2021 · Filed December 03, 2021

Section 16 reporting ended · disclosed 2021-12-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-01 transaction · row 1 1 source row Row 1 · 2021-12-01 · Disposition to issuer · Disposed 28,915 · Balance 0 F1: The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9. F2: In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	8,100	Reported balance After 2021-12-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-12-01 · Grant · Acquired 8,100 · Balance 8,100 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	0	Reported balance After 2021-12-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-12-01 · Disposition to issuer · Disposed 8,100 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	4,064	Reported balance After 2021-12-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-12-01 · Grant · Acquired 4,064 · Balance 4,064 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	0	Reported balance After 2021-12-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-12-01 · Disposition to issuer · Disposed 4,064 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	3,912	Reported balance After 2021-12-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-12-01 · Grant · Acquired 3,912 · Balance 3,912 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	0	Reported balance After 2021-12-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-01 · Disposition to issuer · Disposed 3,912 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	4,389	Reported balance After 2021-12-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-12-01 · Grant · Acquired 4,389 · Balance 4,389 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-12-01 · Disposition to issuer · Disposed 4,389 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	5,936	Reported balance After 2021-12-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-12-01 · Grant · Acquired 5,936 · Balance 5,936 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	0	Reported balance After 2021-12-01 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2021-12-01 · Disposition to issuer · Disposed 5,936 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	4,697	Reported balance After 2021-12-01 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2021-12-01 · Grant · Acquired 4,697 · Balance 4,697 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	0	Reported balance After 2021-12-01 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2021-12-01 · Disposition to issuer · Disposed 4,697 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	8,161	Reported balance After 2021-12-01 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2021-12-01 · Grant · Acquired 8,161 · Balance 8,161 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	0	Reported balance After 2021-12-01 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2021-12-01 · Disposition to issuer · Disposed 8,161 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	11,692	Reported balance After 2021-12-01 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2021-12-01 · Grant · Acquired 11,692 · Balance 11,692 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2021-12-01 · Disposition to issuer · Disposed 11,692 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Common Stock ($1 par value)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	5,685	Reported balance After 2021-12-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-12-01 · Grant · Acquired 5,685 · Balance 5,685 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Common Stock ($1 par value)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	0	Reported balance After 2021-12-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-12-01 · Disposition to issuer · Disposed 5,685 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Stock Equivalent UnitsSEC Table II · derivative / convertible security	Direct	25,282	Reported balance After 2021-12-01 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2021-12-01 · Grant · Acquired 25,282 · Balance 25,282 F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.
Stock Equivalent UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-12-01 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2021-12-01 · Disposition to issuer · Disposed 25,282 · Balance 0 F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9.

F2: In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.

F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price.

F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person.

F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.

F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share.

F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

PRINCIPAL FINANCIAL GROUP INC

Report date June 25, 2021 · Filed June 29, 2021

Section 16 reporting ended · disclosed 2021-05-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security	Direct	8,128	Reported balance After 2021-06-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2021-06-25 · Grant · Acquired 74 · Balance 8,128 F1: The units convert to common stock on a one-for-one basis. F2: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement.

Filing footnotes · ownership attribution and instrument terms

F1: The units convert to common stock on a one-for-one basis.

F2: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 06, 2026 Filed May 8, 2026 20:57 UTC	Moderna, Inc. MRNA · Entity 2025	GrantRestricted Stock Units · Derivative	8,371	$0.00	$0.00	Disclosure SEC source: 0001682852-26-000086 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,371 Underlying: Common Stock · 8,371 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. Read SEC document
April 30, 2026 Filed May 4, 2026 20:44 UTC	Moderna, Inc. MRNA · Entity 2025	Exercise / conversionRestricted Stock Units · Derivative	4,058	$0.00	$0.00	Disclosure SEC source: 0001682852-26-000062 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 30, 2026. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 30, 2026. Read SEC document
April 30, 2026 Filed May 4, 2026 20:44 UTC	Moderna, Inc. MRNA · Entity 2025	Exercise / conversionCommon Stock	4,058	Not disclosed	Not disclosed	Disclosure SEC source: 0001682852-26-000062 · form4.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
April 30, 2025 Filed May 1, 2025 20:36 UTC	Moderna, Inc. MRNA · Entity 2025	GrantRestricted Stock Units · Derivative	4,058	$0.00	$0.00	Disclosure SEC source: 0001127602-25-012946 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,058 Underlying: Common Stock · 4,058 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. F3 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. Read SEC document
April 30, 2025 Filed May 1, 2025 20:36 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	19,134	$0.00 Strike: $28.54	$0.00	Disclosure SEC source: 0001127602-25-012946 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,134 Underlying: Common Stock · 19,134 shares Expires 2035-04-30 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. Read SEC document
May 15, 2024 Filed May 17, 2024 20:26 UTC	Elevance Health, Inc. ELV · Entity 2934	GrantCommon Stock	388	$0.00	$0.00	Disclosure SEC source: 0001156039-24-000089 · wk-form4_1715977592.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,291 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
May 06, 2024 Filed May 7, 2024 20:57 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	7,557	$0.00 Strike: $122.13	$0.00	Disclosure SEC source: 0001127602-24-014468 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,557 Underlying: Common Stock · 7,557 shares Expires 2034-05-06 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
May 10, 2023 Filed May 12, 2023 20:20 UTC	Elevance Health, Inc. ELV · Entity 2934	GrantCommon Stock	457	$0.00	$0.00	Disclosure SEC source: 0001156039-23-000071 · wf-form4_168392281515177.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,903 F1 · shares: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
May 03, 2023 Filed May 5, 2023 20:16 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	6,134	$0.00 Strike: $130.14	$0.00	Disclosure SEC source: 0001127602-23-014683 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,134 Underlying: Common Stock · 6,134 shares Expires 2033-05-03 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
May 18, 2022 Filed May 20, 2022 20:48 UTC	Elevance Health, Inc. ANTM · Entity 2934	GrantCommon Stock	440	$0.00	$0.00	Disclosure SEC source: 0001156039-22-000064 · wf-form4_165307970610208.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,446 F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
April 28, 2022 Filed May 2, 2022 20:39 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	5,415	$0.00 Strike: $142.52	$0.00	Disclosure SEC source: 0001127602-22-012856 · form4.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
April 28, 2022 Filed May 2, 2022 20:39 UTC	Moderna, Inc. MRNA · Entity 2025	Exercise / conversionRestricted Stock Units · Derivative	703	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001127602-22-012856 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document
April 28, 2022 Filed May 2, 2022 20:39 UTC	Moderna, Inc. MRNA · Entity 2025	Exercise / conversionCommon Stock	703	$0.00	$0.00	Disclosure SEC source: 0001127602-22-012856 · form4.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerStock equivalent units · Derivative	25,282	Not disclosed	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 12 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 25,282 shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards. F5 · price: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards. F6 · derivative.exercise_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. F6 · derivative.expiration_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	11,692	Not disclosed Strike: $11.33	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 11 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 11,692 shares Expires 2030-11-11 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	8,161	Not disclosed Strike: $25.22	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 10 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 8,161 shares Expires 2029-11-13 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,697	Not disclosed Strike: $41.83	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 9 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,697 shares Expires 2028-11-14 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F1 · price: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis. F4 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	5,936	Not disclosed Strike: $37.06	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 8 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 5,936 shares Expires 2027-11-08 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	5,685	Not disclosed Strike: $33.96	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 7 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 5,685 shares Expires 2026-11-09 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,389	Not disclosed Strike: $33.51	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 6 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,389 shares Expires 2025-11-11 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	3,912	Not disclosed Strike: $36.51	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 5 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 3,912 shares Expires 2024-11-12 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,064	Not disclosed Strike: $37.29	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 4 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,064 shares Expires 2023-11-06 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	8,100	Not disclosed Strike: $23.03	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 8,100 shares Expires 2022-11-07 F2 · derivative.exercise_price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F2 · price: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Exercise / conversionCommon Stock ($1 par value)	4,697	$41.83	$196,475.51	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · nonDerivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2021 Filed Dec 3, 2021 14:56 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Disposition to issuerCommon Stock ($1 par value)	28,915	Not disclosed	Not disclosed	Disclosure SEC source: 0000065011-21-000166 · wf-form4_163856139560806.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerStock Equivalent Units · Derivative	25,282	Not disclosed	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 21 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 25,282 shares Expires not disclosed F6 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F6 · price: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F7 · derivative.exercise_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. F7 · derivative.expiration_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantStock Equivalent Units · Derivative	25,282	Not disclosed	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 20 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,282 Underlying: Common Stock ($1 par value) · 25,282 shares Expires not disclosed F6 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F7 · derivative.exercise_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. F7 · derivative.expiration_date: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	11,692	Not disclosed Strike: $11.33	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 19 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 11,692 shares Expires 2030-11-11 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	11,692	Not disclosed Strike: $11.33	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 18 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,692 Underlying: Common Stock ($1 par value) · 11,692 shares Expires 2030-11-11 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	8,161	Not disclosed Strike: $25.22	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 17 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 8,161 shares Expires 2029-11-13 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	8,161	Not disclosed Strike: $25.22	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 16 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,161 Underlying: Common Stock ($1 par value) · 8,161 shares Expires 2029-11-13 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,697	Not disclosed Strike: $41.83	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 15 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,697 shares Expires 2028-11-14 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,697	Not disclosed Strike: $41.83	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 14 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Underlying: Common Stock ($1 par value) · 4,697 shares Expires 2028-11-14 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	5,936	Not disclosed Strike: $37.06	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 13 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 5,936 shares Expires 2027-11-08 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	5,936	Not disclosed Strike: $37.06	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 12 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 Underlying: Common Stock ($1 par value) · 5,936 shares Expires 2027-11-08 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerCommon Stock ($1 par value) · Derivative	5,685	Not disclosed Strike: $33.96	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 11 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 5,685 shares Expires 2026-11-09 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantCommon Stock ($1 par value) · Derivative	5,685	Not disclosed Strike: $33.96	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 10 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,685 Underlying: Common Stock ($1 par value) · 5,685 shares Expires 2026-11-09 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,389	Not disclosed Strike: $33.51	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 9 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,389 shares Expires 2025-11-11 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,389	Not disclosed Strike: $33.51	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 8 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,389 Underlying: Common Stock ($1 par value) · 4,389 shares Expires 2025-11-11 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	3,912	Not disclosed Strike: $36.51	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 7 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 3,912 shares Expires 2024-11-12 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	3,912	Not disclosed Strike: $36.51	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 6 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,912 Underlying: Common Stock ($1 par value) · 3,912 shares Expires 2024-11-12 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	4,064	Not disclosed Strike: $37.29	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 5 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 4,064 shares Expires 2023-11-06 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,064	Not disclosed Strike: $37.29	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 4 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,064 Underlying: Common Stock ($1 par value) · 4,064 shares Expires 2023-11-06 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	8,100	Not disclosed Strike: $23.03	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 8,100 shares Expires 2022-11-07 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F3 · price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	GrantNon-Qualified Stock Option (right to buy) · Derivative	8,100	Not disclosed Strike: $23.03	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Common Stock ($1 par value) · 8,100 shares Expires 2022-11-07 F3 · derivative.exercise_price: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4 · shares: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F4 · price: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5 · derivative.exercise_date: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant. Read SEC document
December 01, 2021 Filed Dec 3, 2021 20:07 UTC	Meredith Holdings Corp NONE · Entity 132729	Disposition to issuerCommon Stock ($1 par value)	28,915	Not disclosed	Not disclosed	Disclosure SEC source: 0001880863-21-000074 · wf-form4_163856201012671.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9. F2 · price: In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share. Read SEC document
November 09, 2021 Filed Nov 12, 2021 14:36 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantCommon Stock ($1 par value)	2,322	$0.00	$0.00	Disclosure SEC source: 0000065011-21-000123 · wf-form4_163674578008704.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,915 F1 · shares: This restricted stock award was awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan. The share are subject to forfeiture and non-transferable until vested. Restrictions on the shares lapse on 1/3 of the shares per year commencing on the first anniversary of the grant date. Read SEC document
July 14, 2021 Filed Jul 16, 2021 15:08 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Exercise / conversionCommon Stock ($1 par value) · Derivative	10,845	$0.00 Strike: $26.55	$0.00	Disclosure SEC source: 0000065011-21-000040 · wf-form4_162646251131228.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 10,845 shares Expires 2021-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date. Read SEC document
July 14, 2021 Filed Jul 16, 2021 15:08 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Tax withholdingCommon Stock ($1 par value)	6,946	$41.46	$287,946.43	Disclosure SEC source: 0000065011-21-000040 · wf-form4_162646251131228.xml · nonDerivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,593 Read SEC document
July 14, 2021 Filed Jul 16, 2021 15:08 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Exercise / conversionCommon Stock ($1 par value)	10,845	$26.55	$287,934.75	Disclosure SEC source: 0000065011-21-000040 · wf-form4_162646251131228.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.